Koyfin Home > Directory > Health Care > Akebia Therapeutics > EV / EBITDA (ntm)

Akebia Therapeutics EV / EBITDA (ntm) Chart (AKBA)

Akebia Therapeutics annual/quarterly EV / EBITDA (ntm) from 2015 to 2015. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Akebia Therapeutics EV / EBITDA (ntm) for the quarter ending July 07, 2015 was 23.22 a -14.93% decrease of -3.47 year over year
  • Akebia Therapeutics EV / EBITDA (ntm) for the last 12 months ending July 07, 2015 was 23.22 a -14.93% decrease of -3.47 year over year
  • Akebia Therapeutics Annual EV / EBITDA (ntm) for 2015 was 23.22 a -10.02% decrease of -2.33 from 2014
  • Akebia Therapeutics Annual EV / EBITDA (ntm) for 2015 was 25.54 a -5.13% decrease of -1.31 from 2014
  • Akebia Therapeutics Annual EV / EBITDA (ntm) for 2015 was 26.85 a 0.63% increase of 0.17 from 2014
Other Valuation Metrics:
  • Akebia Therapeutics Market Cap for the quarter ending March 03, 2018 was $535m a -24.92% decrease of -133m year over year
  • Akebia Therapeutics Price / Book for the quarter ending March 03, 2018 was 3.80 a -378.76% decrease of -14.40 year over year
  • Akebia Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $217m a -91.84% decrease of -199m year over year
View Chart On Koyfin

Quarterly AKBA EV / EBITDA (ntm) Data

07/201523.22
07/201525.54
07/201526.85
07/201526.68
07/201526.43
06/201528.80
06/201524.91
06/201525.75
06/201525.08
06/201524.61

Annual AKBA EV / EBITDA (ntm) Data

201523.22
201525.54
201526.85
201526.68
201526.43
201528.80
201524.91
201525.75
201525.08
201524.61